41
SynCore Biotechnology Co.,Ltd
4192.TWO · TWO
$18.30 -1.08% (-$0.20)
1M -1.31%
Market Cap $650.6M
P/E Ratio -
Div. Yield -
ROE 18.70%
Piotroski F-Score Moderate
5/9Valuation
35 /100
Fair P/B 2.80x
P/S 24.79x
EV/EBITDA N/A
Growth
83 /100
Growing Book val. growth 0.46%
Rev. growth 19.48%
FCF growth N/A
Profitability
20 /100
Weak Net margin 178.54%
Op. margin 194.10%
FCF margin 120.58%
Quality
1 /100
Poor ROE 18.70%
ROA 18.30%
Asset turnover 0.10x
Debt
69 /100
Low Current ratio 11.41x
Int. coverage -522.73x
Debt/Equity 0.06x
Stability
37 /100
Moderate Rev. volatility 6.73%
EPS volatility 48,694.44%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 4192.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chih-Wen Lee
Employees
40
Headquarters
Yilan City